Blue Bay Capital

Blue Bay Capital, also known as Lanwan Capital, is a venture capital firm based in China that specializes in the healthcare and life sciences sectors. The firm focuses on identifying and investing in high-growth companies involved in innovative drug discovery, medical technology, and healthcare services. Blue Bay Capital provides not only financial backing but also strategic guidance to its portfolio companies, leveraging a deep network within the Chinese regulatory and clinical landscape. Its investment strategy covers various stages of development, from early-stage incubation to late-stage growth capital. The firm has been a key investor in several successful biotech companies that have achieved significant clinical milestones and public listings. Notable portfolio companies include Abbisko Therapeutics, InnoCare Pharma, and Antengene.